Free radicals in anticancer drug pharmacology
- 31 December 1989
- journal article
- review article
- Published by Elsevier in Chemico-Biological Interactions
- Vol. 69 (4), 293-317
- https://doi.org/10.1016/0009-2797(89)90117-8
Abstract
No abstract availableKeywords
This publication has 73 references indexed in Scilit:
- DNA damage, cytotoxicity and free radical formation by mitomycin C in human cellsChemico-Biological Interactions, 1989
- Interactions of the antitumor drug, etoposide, with reduced thiols in vitro and in vivoChemico-Biological Interactions, 1987
- Peroxidative free radical formation and O-demethylation of etoposide(VP-16) and teniposide(VM-26)Biochemical and Biophysical Research Communications, 1986
- Prevention of doxorubicin-induced killing of MCF-7 human breast cancer cells by oxygen radical scavengers and iron chelating agentsBiochemical and Biophysical Research Communications, 1986
- Diaziquone as a potential agent for photoirradiation therapy: Formation of the semiquinone and hydroxyl radicals by visible lightBiochemical and Biophysical Research Communications, 1985
- Decompostion of unsaturated phospholipid by iron-ADP-adriamycin co-ordination complexBiochemical and Biophysical Research Communications, 1981
- Binding specificity of chemically and enzymatically activated anthracycline anticancer agents to nucleic acidsChemico-Biological Interactions, 1980
- Metabolic activation of procarbazineLife Sciences, 1978
- Streptonigrin-transition metal complexes: Binding to DNA and biological activityBiochemical and Biophysical Research Communications, 1977
- H2O2 generation during the redox cycle of mitomycin C and DNA-bound mitomycin CChemico-Biological Interactions, 1976